Cargando…

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer

Resistance to docetaxel is a major clinical problem in advanced prostate cancer (PCa). Although glucocorticoids (GCs) are frequently used in combination with docetaxel, it is unclear to what extent GCs and their receptor, the glucocorticoid receptor (GR), contribute to the chemotherapy resistance. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kroon, Jan, Puhr, Martin, Buijs, Jeroen T, van der Horst, Geertje, Hemmer, Daniëlle M, Marijt, Koen A, Hwang, Ming S, Masood, Motasim, Grimm, Stefan, Storm, Gert, Metselaar, Josbert M, Meijer, Onno C, Culig, Zoran, van der Pluijm, Gabri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657186/ https://www.ncbi.nlm.nih.gov/pubmed/26483423 http://dx.doi.org/10.1530/ERC-15-0343

Ejemplares similares

Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
por: Kroon, Jan, et al.
Publicado: (2015)

Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth
por: Kroon, Jan, et al.
Publicado: (2013)

The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis
por: van den Hoogen, Christel, et al.
Publicado: (2011)

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
por: Vrouwe, Josephina P. M., et al.
Publicado: (2021)

Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
por: Culig, Zoran, et al.
Publicado: (2012)

Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness
por: Wissing, Michel D., et al.
Publicado: (2014)

Scale-Up of the Manufacturing Process To Produce Docetaxel-Loaded mPEG-b-p(HPMA-Bz) Block Copolymer Micelles for Pharmaceutical Applications
por: Bresseleers, Jaleesa, et al.
Publicado: (2019)

p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer
por: Gruber, Martina, et al.
Publicado: (2020)

The stem cell inhibitor salinomycin decreases colony formation potential and tumor‐initiating population in docetaxel‐sensitive and docetaxel‐resistant prostate cancer cells
por: Gruber, Martina, et al.
Publicado: (2019)

Oncolytic activity of the rhabdovirus VSV‐GP against prostate cancer
por: Urbiola, Carles, et al.
Publicado: (2018)

The role of microRNAs in bone metastasis
por: Zoni, Eugenio, et al.
Publicado: (2016)

PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
por: Puhr, Martin, et al.
Publicado: (2014)

The role of epithelial–mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel‐resistant prostate cancer
por: Hanrahan, Karen, et al.
Publicado: (2017)

Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer
por: Lima, Thiago S., et al.
Publicado: (2022)

The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers
por: van de Merbel, Arjanneke F., et al.
Publicado: (2021)

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells
por: Vakhrusheva, Olesya, et al.
Publicado: (2022)

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe
por: Drápela, Stanislav, et al.
Publicado: (2020)

miR-25, integrin and cancer invasiveness
por: Zoni, Eugenio, et al.
Publicado: (2015)

Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer
por: Puhr, Martin, et al.
Publicado: (2021)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018)

Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma
por: van der Horst, Geertje, et al.
Publicado: (2014)

Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition
por: Viho, Eva M G, et al.
Publicado: (2022)

Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation
por: Riplinger, Selina M, et al.
Publicado: (2014)

An ex vivo Tissue Culture Model for the Assessment of Individualized Drug Responses in Prostate and Bladder Cancer
por: van de Merbel, Arjanneke F., et al.
Publicado: (2018)

Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT
por: Zoni, Eugenio, et al.
Publicado: (2015)

Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program
por: Taurozzi, Alberto J., et al.
Publicado: (2017)

Challenges in nanomedicine clinical translation
por: Metselaar, Josbert M., et al.
Publicado: (2020)

A(2A) Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction
por: Hurtado-Alvarado, Gabriela, et al.
Publicado: (2016)

BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β(3) expression
por: Naber, Hildegonda P. H., et al.
Publicado: (2011)

A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa
por: van den Akker, Peter C., et al.
Publicado: (2018)

Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment
por: Alaarg, Amr, et al.
Publicado: (2016)

Will It Revert to Pageantry and Burlesque?
Publicado: (1920)

Sex and Stress Steroid Crosstalk Reviewed: Give Us More
por: Kroon, Jan, et al.
Publicado: (2020)

Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase
por: Buijs, Jeroen T, et al.
Publicado: (2015)

Recent Advances in Liposomal-Based Anti-Inflammatory Therapy
por: van Alem, Carla M. A., et al.
Publicado: (2021)

Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide
por: Hoefer, Julia, et al.
Publicado: (2016)

The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice
por: Buijs, Jeroen T., et al.
Publicado: (2019)

Revertant Mosaicism in Epidermolysis Bullosa
por: Meyer-Mueller, Cameron, et al.
Publicado: (2022)

Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
por: Wong, Chee Wai, et al.
Publicado: (2018)

XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice
por: Semenchenko, Kostyantyn, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7f3t5n9a0lh7jg9mpkaautqkbc